The Society of Nuclear Medicine & Molecular Imaging (SNMMI) is lauding the Senate Appropriations Committee for including nuclear medicine research language in its reports to Labor, Health, and Human Services (L-HHS) and the Department of Defense (DoD) for the 2026 fiscal year.
The L-HHS report includes language from SNMMI encouraging the National Institutes of Health's National Cancer Institute (NCI) to support research for theranostics to provide early, accurate, and effective cancer diagnosis and treatment.
The DoD report includes neuroendocrine tumors as an allowable research area in the Congressionally Directed Medical Research Program's (CDMRP) Peer-Reviewed Cancer Research Program.
The House of Representatives has not voted on the L-HHS and DoD bills. The SNMMI said that reports are not expected to be released until early September.
